HCAT Health Catalyst Inc

Price (delayed)

$6.48

Market cap

$379.49M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.09

Enterprise value

$522.28M

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage ...

Highlights
HCAT's EPS is up by 18% year-on-year and by 7% since the previous quarter
The net income has grown by 14% YoY and by 4.4% from the previous quarter
Health Catalyst's quick ratio has decreased by 15% YoY and by 9% from the previous quarter
The company's equity fell by 14% YoY and by 4% QoQ

Key stats

What are the main financial stats of HCAT
Market
Shares outstanding
58.56M
Market cap
$379.49M
Enterprise value
$522.28M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.02
Price to sales (P/S)
1.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.76
Earnings
Revenue
$295.94M
EBIT
-$126.9M
EBITDA
-$81.68M
Free cash flow
-$46.24M
Per share
EPS
-$2.09
Free cash flow per share
-$0.82
Book value per share
$6.38
Revenue per share
$5.25
TBVPS
$7.76
Balance sheet
Total assets
$701.81M
Total liabilities
$334.9M
Debt
$249.07M
Equity
$366.92M
Working capital
$304.36M
Liquidity
Debt to equity
0.68
Current ratio
4.42
Quick ratio
4.25
Net debt/EBITDA
-1.75
Margins
EBITDA margin
-27.6%
Gross margin
44.5%
Net margin
-39.9%
Operating margin
-42.9%
Efficiency
Return on assets
-16.4%
Return on equity
-30.6%
Return on invested capital
-25.2%
Return on capital employed
-20.7%
Return on sales
-42.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

HCAT stock price

How has the Health Catalyst stock price performed over time
Intraday
-0.92%
1 week
7.46%
1 month
-3.14%
1 year
-48.41%
YTD
-30.02%
QTD
-13.94%

Financial performance

How have Health Catalyst's revenue and profit performed over time
Revenue
$295.94M
Gross profit
$131.83M
Operating income
-$126.9M
Net income
-$118.15M
Gross margin
44.5%
Net margin
-39.9%
The company's net margin rose by 20% YoY and by 6% QoQ
The operating margin rose by 15% YoY and by 4.9% QoQ
The net income has grown by 14% YoY and by 4.4% from the previous quarter
The operating income is up by 9% year-on-year and by 3% since the previous quarter

Growth

What is Health Catalyst's growth rate over time

Valuation

What is Health Catalyst stock price valuation
P/E
N/A
P/B
1.02
P/S
1.24
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.76
HCAT's EPS is up by 18% year-on-year and by 7% since the previous quarter
HCAT's price to book (P/B) is 71% lower than its 5-year quarterly average of 3.5 and 36% lower than its last 4 quarters average of 1.6
The company's equity fell by 14% YoY and by 4% QoQ
The stock's price to sales (P/S) is 78% less than its 5-year quarterly average of 5.6 and 41% less than its last 4 quarters average of 2.1
The company's revenue rose by 7% YoY and by 2% QoQ

Efficiency

How efficient is Health Catalyst business performance
HCAT's ROS is up by 15% year-on-year and by 4.9% since the previous quarter
Health Catalyst's return on assets has increased by 10% YoY and by 2.4% QoQ
The ROIC has grown by 6% YoY
HCAT's return on equity is up by 5% year-on-year

Dividends

What is HCAT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HCAT.

Financial health

How did Health Catalyst financials performed over time
HCAT's total assets is 110% greater than its total liabilities
The current ratio has contracted by 15% YoY and by 9% from the previous quarter
Health Catalyst's quick ratio has decreased by 15% YoY and by 9% from the previous quarter
The company's debt is 32% lower than its equity
The debt to equity is up by 17% year-on-year and by 4.6% since the previous quarter
The company's equity fell by 14% YoY and by 4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.